Atlas FDA

Xstim Spine Fusion Stimulator

FDA premarket approval P230025 · decided 2024-02-09

Approval details

PMA number
P230025
Trade name
Xstim Spine Fusion Stimulator
Generic name
Stimulator, bone growth, non-invasive
Applicant
Xstim, Inc.
Date received
2023-08-15
Decision date
2024-02-09
Days to decision
178 days
Decision code
APPR
Product code
LOF
Advisory committee
Orthopedic
Expedited review
No
Location
Irving, TX
Statement
The Xstim Spine Fusion Stimulator is a non-invasive bone growth stimulator indicated as an adjunct electrical treatment to primary lumbar spinal fusion surgery for one or two levels. The device is for prescription use only and is intended for single patient use in adult patients only.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.